Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Do | CMS Energy's Arm Announces Plans to Upgrade Natural Gas System | ||
Do | Here's Why You Should Retain Eastman Chemical Stock in Your Portfolio | ||
Do | Enersys Provides Update on IRC 45X Tax Benefits, Raises Q3 Guidance | ||
Do | Will BCE Stock Gain From Bell Media's Alliance With Shopsense AI? | ||
Do | Quantum's Myriad Boosts NVIDIA GPUDirect Storage, QMCO Stock Up 153% | ||
Do | PENN Debuts Stand-Alone Hollywood Casino App in Pennsylvania | ||
Do | Williams Up 49% in 2024: Should Investors Cash Out or Hold On? | ||
Do | ARAY Stock Falls Despite Positive Data of CyberKnife in Treating BSM | ||
Do | Fed Signals Fewer Rate Cuts in 2025: 4 Low-Beta Staples Stocks to Buy | ||
Do | Dow and Innventure to Partner on Waste-to-Value Platform | ||
Do | Will Viasat's Non-Core Asset Sale for Core Focus Aid the Stock? | ||
Do | SRPT Finishes Enrolment in Late-Stage Study for Rare Muscular Disorder | ||
Do | Ameris Bancorp Rewards Shareholders With a 33.3% Dividend Hike | ||
Do | Fed Turns Hawkish, Signals Fewer 2025 Cuts: What This Means for Banks | ||
Do | Permian Powerhouses: 3 Oil Stocks to Watch Closely in 2025 | ||
Do | 5 Low-Beta High-Yielding Stocks to Buy Amid Fed-Induced Volatility | ||
Do | CDNS Rises 10% YTD: Should Investors Add the Stock to Their Portfolio? | ||
Do | Buy 5 Investment Management Stocks to Enrich Your Portfolio in 2025 | ||
Do | Merck Enters Obesity Space, Buys Rights to Hansoh's Oral GLP-1 Drug | ||
Do | DOW Stock Down 24% in 3 Months: Should You Buy the Dip? | ||
Do | AMSC Stock Trading at a Premium Value: Should You Buy, Sell or Hold? | ||
Do | Looking for Earnings Beat? Buy These 5 Top-Ranked Stocks | ||
Do | Forget the Fed, Bet on These 4 Stocks With Increasing Cash Flows | ||
Do | Looking for Outsized Gains in 2025? Buy 3 Breakout Stocks Now | ||
Do | CCL Stock Before Q4 Earnings: Should You Buy Now or Wait for Results? |